ATE537153T1 - Arylspirolactamverbindungen als antagonisten des cgrp-rezeptors - Google Patents

Arylspirolactamverbindungen als antagonisten des cgrp-rezeptors

Info

Publication number
ATE537153T1
ATE537153T1 AT05793937T AT05793937T ATE537153T1 AT E537153 T1 ATE537153 T1 AT E537153T1 AT 05793937 T AT05793937 T AT 05793937T AT 05793937 T AT05793937 T AT 05793937T AT E537153 T1 ATE537153 T1 AT E537153T1
Authority
AT
Austria
Prior art keywords
compounds
antagonists
arylspirolactam
cgrp receptor
cgrp
Prior art date
Application number
AT05793937T
Other languages
English (en)
Inventor
Ian Bell
Craig Stump
Cory Theberge
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE537153T1 publication Critical patent/ATE537153T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/96—Spiro-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT05793937T 2004-09-09 2005-09-06 Arylspirolactamverbindungen als antagonisten des cgrp-rezeptors ATE537153T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60848904P 2004-09-09 2004-09-09
PCT/US2005/031712 WO2006031513A2 (en) 2004-09-09 2005-09-06 Aryl spirolactam cgrp receptor antagonists

Publications (1)

Publication Number Publication Date
ATE537153T1 true ATE537153T1 (de) 2011-12-15

Family

ID=36060525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05793937T ATE537153T1 (de) 2004-09-09 2005-09-06 Arylspirolactamverbindungen als antagonisten des cgrp-rezeptors

Country Status (8)

Country Link
US (1) US7989624B2 (de)
EP (1) EP1794133B1 (de)
JP (1) JP2008512459A (de)
CN (1) CN101014576B (de)
AT (1) ATE537153T1 (de)
AU (1) AU2005285292B2 (de)
CA (1) CA2580020A1 (de)
WO (1) WO2006031513A2 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005285083B2 (en) * 2004-09-13 2011-03-10 Merck Sharp & Dohme Corp. Tricyclic anilide spirohydantoin CGRP receptor antagonists
US7968540B2 (en) 2005-11-18 2011-06-28 Merck Sharp & Dohme Corp. Spirohydantoin tricyclic CGRP receptor antagonists
CA2629406A1 (en) 2005-11-18 2007-05-31 Merck & Co., Inc. Spirohydantoin aryl cgrp receptor antagonists
EP1951042B1 (de) 2005-11-18 2012-10-10 Merck Sharp & Dohme Corp. Spirolactam tricyclische cgrp-rezeptor-antagonisten
EP1954135B1 (de) * 2005-11-18 2012-10-10 Merck Sharp & Dohme Corp. Spirolactam-aryl cgrp-rezeptor-antagonisten
WO2007133491A1 (en) 2006-05-09 2007-11-22 Merck & Co., Inc. Substituted spirocyclic cgrp receptor antagonists
US7951795B2 (en) * 2006-12-08 2011-05-31 Merck Sharp & Dohme Corp. Constrained spirocyclic compounds as CGRP receptor antagonists
US8372859B2 (en) * 2007-04-11 2013-02-12 Merck, Sharp & Dohme Corp. CGRP receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups
CA2683745A1 (en) * 2007-04-16 2008-10-30 Merck & Co., Inc. Bicyclic anilide heterocyclic cgrp receptor antagonists
WO2008130524A1 (en) * 2007-04-16 2008-10-30 Merck & Co., Inc. Aryl heterocyclic cgrp receptor antagonists
CA2689217C (en) * 2007-06-05 2016-02-16 Merck & Co., Inc. Carboxamide heterocyclic cgrp receptor antagonists
US8163752B2 (en) * 2007-06-07 2012-04-24 Merck, Sharp & Dohme Corp. Tricyclic anilide heterocyclic CGRP receptor antagonists
NZ585347A (en) 2007-10-18 2011-09-30 Boehringer Ingelheim Int Cgrp antagonists
EP2065386A1 (de) * 2007-10-18 2009-06-03 Boehringer Ingelheim Pharma GmbH & Co. KG CGRP Antagonisten
EP2065381A1 (de) 2007-10-18 2009-06-03 Boehringer Ingelheim Pharma GmbH & Co. KG CGRP Antagonisten
EP2225223B1 (de) 2007-11-22 2017-01-11 Boehringer Ingelheim International GmbH Organische verbindungen
EP2331101A4 (de) * 2008-09-08 2012-08-29 Merck Sharp & Dohme Monozyklische amid-cgrp-rezeptorantagonisten
WO2010077752A1 (en) 2008-12-17 2010-07-08 Merck Sharp & Dohme Corp. Imidazolinone derivatives as cgrp receptor antagonists
EP2379529B1 (de) 2008-12-19 2015-06-10 Boehringer Ingelheim International Gmbh Cgrp-antagonisten
US8778957B2 (en) 2009-03-18 2014-07-15 Merck Sharp & Dohme Corp. CGRP receptor antagonists
TW201118069A (en) * 2009-10-28 2011-06-01 Lundbeck & Co As H Spirolactam derivatives and uses of same
CN105308049A (zh) * 2013-01-29 2016-02-03 阿普廷伊克斯股份有限公司 螺-内酰胺nmda受体调节剂及其用途
EP3366286A1 (de) 2017-02-22 2018-08-29 Johannes Keller Verbindungen zur behandlung von sepsis
GB201707938D0 (en) * 2017-05-17 2017-06-28 Univ Sheffield Compounds
GB201818651D0 (en) * 2018-11-15 2019-01-02 Univ Sheffield Compounds
CN116730905B (zh) * 2023-06-08 2025-10-03 江苏海洋大学 一种含羰全碳季碳螺环假吲哚的合成方法
CN116813528B (zh) * 2023-06-30 2026-02-27 江苏海洋大学 一种全碳季碳环酮螺环假吲哚衍生物的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9711376B (en) * 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives
DE19952147A1 (de) * 1999-10-29 2001-05-03 Boehringer Ingelheim Pharma Neue Cyclopropane, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
ES2616539T3 (es) * 2002-06-05 2017-06-13 Bristol-Myers Squibb Company Antagonistas de receptores de péptidos relacionados con el gen de calcitonina
DE10250080A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
EP1606286B1 (de) 2003-03-14 2011-05-11 Merck Sharp & Dohme Corp. Benzodiazepinspirohydantoine als cgrp-rezeptorantagonisten
AU2004222328B2 (en) 2003-03-14 2009-10-08 Merck Sharp & Dohme Corp. Aryl spirohydantoin CGRP receptor antagonists
JP4673294B2 (ja) 2003-03-14 2011-04-20 メルク・シャープ・エンド・ドーム・コーポレイション 二環式アニリドスピロヒダントインcgrp受容体拮抗物質
EP1606264B1 (de) * 2003-03-14 2012-05-02 Merck Sharp & Dohme Corp. Monocyclische anilidspirohydantoine als cgrp-rezeptorantagonisten
JP2008512460A (ja) 2004-09-08 2008-04-24 メルク エンド カムパニー インコーポレーテッド 単環式アニリドスピロラクタムcgrp受容体拮抗薬
CA2579717A1 (en) * 2004-09-09 2006-03-23 Merck & Co., Inc. Tricyclic anilide spirolactam cgrp receptor antagonists
US7390798B2 (en) * 2004-09-13 2008-06-24 Merck & Co., Inc. Carboxamide spirolactam CGRP receptor antagonists
US8003792B2 (en) 2004-09-13 2011-08-23 Merck Sharp & Dohme Corp. Bicyclic anilide spirolactam CGRP receptor antagonists
WO2007133491A1 (en) * 2006-05-09 2007-11-22 Merck & Co., Inc. Substituted spirocyclic cgrp receptor antagonists

Also Published As

Publication number Publication date
US20080004304A1 (en) 2008-01-03
WO2006031513A2 (en) 2006-03-23
CN101014576A (zh) 2007-08-08
EP1794133A4 (de) 2010-01-27
US7989624B2 (en) 2011-08-02
CA2580020A1 (en) 2006-03-23
WO2006031513A3 (en) 2006-07-13
CN101014576B (zh) 2011-05-25
JP2008512459A (ja) 2008-04-24
AU2005285292A1 (en) 2006-03-23
EP1794133A2 (de) 2007-06-13
EP1794133B1 (de) 2011-12-14
AU2005285292B2 (en) 2011-03-10

Similar Documents

Publication Publication Date Title
DE602005020656D1 (de) Bicyclische anilidspirolactame als antagonisten des cgrp-rezeptors
EP1794133A4 (de) Arylspirolactamverbindungen als antagonisten des cgrp-rezeptors
WO2006031606A3 (en) Carboxamide spirolactam cgrp receptor antagonists
DE602005020472D1 (de) Tricyclische anilid-spirohydantoin-cgrp-rezeptorantagonisten
WO2006029153A3 (en) Monocyclic anilide spirolactam cgrp receptor antagonists
NO20072435L (no) CGRP-reseptorantagonister
TW200505903A (en) CGRP receptor antagonists
ATE394400T1 (de) Bicyclische anilidspirohydantoine als cgrp- rezeptorantagonisten
ATE466860T1 (de) Cgrp-rezeptorantagonisten
EP1606286A4 (de) Benzodiazepinspirohydantoine als cgrp-rezeptorantagonisten
ATE535514T1 (de) Carboxamid-spirohydantoin-cgrp-rezeptor- antagonisten
ATE537170T1 (de) Cgrp-rezeptorantagonisten
ATE516803T1 (de) Aryl-spirohydantoin-cgrp-rezeptor-antagonisten
WO2008112159A3 (en) Monocyclic anilide spirolactam cgrp receptor antagonists
ATE556060T1 (de) Monocyclische anilidspirohydantoine als cgrp- rezeptorantagonisten
EP1794146A4 (de) Tricyclische anilid-spirohydantoin-cgrp-rezeptorantagonisten
EP1804919A4 (de) Cgrp-rezeptorantagonisten
EP1802372A4 (de) Cgrp-rezeptorantagonisten
ATE466853T1 (de) Cgrp-rezeptorantagonisten